56442-43-4

Basic information

• Product Name: Benzamide, 4-(phenylmethoxy)-
• CAS NO: 56442-43-4
• Molecular Formula: C14H13NO2
• Molecular Weight: 227.263
• Mol File: 56442-43-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzamide, 4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 4-(phenylmethoxy)-(56442-43-4)
• EPA Substance Registry System: Benzamide, 4-(phenylmethoxy)-(56442-43-4)

Safety Data

• Hazardous Substances Data: 56442-43-4(Hazardous Substances Data)

Upstream product

• 4397-53-9 p-benzyloxybenzaldehyde 
• 1486-51-7 p-(benzyloxy)benzoic acid 
• 100-44-7 benzyl chloride 
• 767-00-0 4-cyanophenol 
• 836-43-1 4-benzyloxybenzyl alcohol 
• 76193-67-4 4-benzyloxybenzaldehyde oxime 
• 52805-36-4 4-benzyloxybenzonitrile 

Downstream Products

• 952117-47-4 tert-butyl (4-(benzyloxy)benzoyl)carbamate 
• 1228350-25-1 C₄₂H₅₂NO₉P 
• 193535-31-8 C₂₈H₃₉NO₆ 
• 1228350-24-0 C₃₅H₄₃NO₆ 
• 1188441-16-8 C₂₈H₄₀NO₉P 
• 1134784-66-9 5-(4-benzyloxy-phenyl)-[1,3,4]oxathiazol-2-one 
• 521266-49-9 (2S)-1-({2-[2-(4-Benzyloxy-phenyl)-5-methyl-oxazol-4-yl]-ethylamino}-acetyl)-pyrrolidine-2-carbonitrile 
• 521266-51-3 2-[2-(4-benzyloxy-phenyl)-5-methyl-oxazol-4-yl]-ethylamine 
• 202594-65-8 2-(4-benzyloxy-phenyl)-4-chloromethyl-oxazole 

Relevant articles and documents

Efficient Route to Deuterated Aromatics by the Deamination of Anilines

One-step replacement of NH2 groups in ring-substituted anilines by deuterium is reported. Approaches comprising both solid-phase and solution-phase syntheses can be used on a large variety of substrates. The method uses diazotization in a mixture of water and either dichloromethane or chloroform, which serve as a source of hydrogen. This protocol can be used as a general method for fast and easy incorporation of deuterium into an aromatic system using deuterated chloroform.

ANTIBACTERIAL AGENTS

Compounds of formula (IA) or (IB) have antibacterial activity: wherein W is =CH- or =N-; Ri and R2 are independently selected from hydrogen, fluoro and chloro, provided that Ri and R2 are not each hydrogen when W is =CH-; n is 0 or 1; X is -O-, -S-, or -C

1-′(E)-2-(PHENYL) ETHENYL-4-(ARYLALKOXY)-OXAZOLE OR - THIAZOLE COMPOUNDS AS HER-2 TYROSINE KINASES INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER

Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms thereof, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their